Retour
43
Fourchette du Jour
367,87 €
367,90 €
Fourchette 52 Semaines
362,28 €
535,75 €
Volume
1
Moyenne 50J / 200J
383,12 €
/
435,98 €
Clôture Précédente
367,90 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 57,4 | 0,2 |
| P/B | 7,4 | 3,0 |
| ROE % | 13,5 | 3,5 |
| Net Margin % | 11,7 | 3,8 |
| Rev Growth 5Y % | 16,7 | 9,7 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
18,21 €
16,86 € – 18,81 €
|
1,02B | 1 |
| FY2029 |
18,37 €
17,01 € – 18,97 €
|
932,81M | 1 |
| FY2028 |
15,60 €
14,44 € – 16,11 €
|
801,81M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-11 | 11,44 € | 12,79 € | +11,8% |
| 2025-05-20 | N/A | 2,36 € | — |
| 2024-12-31 | N/A | 2,21 € | — |
| 2024-11-13 | 3,34 € | 1,39 € | -58,4% |
| 2024-06-30 | N/A | 1,33 € | — |
| 2024-06-26 | N/A | 3,38 € | — |
| 2023-12-31 | N/A | 1,79 € | — |
| 2023-11-15 | N/A | 2,92 € | — |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,31%
Growth (3Y)
30,45%
Growth (5Y)
45,42%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Jul 07, 2025 | Jul 08, 2025 | 1,39 € | 0,33% |
| Jul 02, 2024 | Jul 03, 2024 | 1,11 € | 0,31% |
| Jul 03, 2023 | Jul 05, 2023 | 1,45 € | 0,97% |
| Jul 04, 2022 | Jul 06, 2022 | 0,62 € | 0,42% |
| Jul 07, 2021 | Jul 09, 2021 | 0,63 € | 0,42% |
| Jul 08, 2020 | Jul 10, 2020 | 0,21 € | 0,14% |
| Jul 03, 2019 | Jul 05, 2019 | 0,56 € | 0,37% |
| Jul 03, 2018 | Jul 05, 2018 | 1,41 € | 0,94% |
| Jul 04, 2017 | Jul 06, 2017 | 1,35 € | 0,90% |
| Jul 05, 2016 | Jul 07, 2016 | 1,02 € | 0,68% |
| Jul 06, 2015 | Jul 08, 2015 | 0,64 € | 0,42% |
| Jul 07, 2014 | Jul 10, 2014 | 0,34 € | 0,22% |
| Jul 08, 2013 | Jul 11, 2013 | 0,21 € | 0,14% |
| Jul 09, 2012 | Jul 12, 2012 | 0,20 € | 0,14% |
| Jul 12, 2011 | Jul 15, 2011 | 0,24 € | 0,16% |
Points Clés
Revenue grew 16,71% annually over 5 years — strong growth
ROE of 13,49% — decent returns on equity
Debt/Equity of 0,39 — conservative balance sheet
Negative free cash flow of -128,95M
P/E of 57,37 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 19,83%
Croissance
Revenue Growth (5Y)
16,71%
Revenue (1Y)36,54%
Earnings (1Y)11,66%
FCF Growth (3Y)N/A
Qualité
Return on Equity
13,49%
ROIC8,94%
Net Margin11,68%
Op. Margin15,07%
Sécurité
Debt / Equity
0,39
Current Ratio0,86
Interest Coverage16,99
Valorisation
P/E Ratio
57,37
Forward P/E30,70
P/B Ratio7,39
EV/EBITDA46,53
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36,54% | Revenue Growth (3Y) | 22,69% |
| Earnings Growth (1Y) | 11,66% | Earnings Growth (3Y) | 30,64% |
| Revenue Growth (5Y) | 16,71% | Earnings Growth (5Y) | 96,99% |
| Profitability | |||
| Revenue (TTM) | 748,87M | Net Income (TTM) | 87,50M |
| ROE | 13,49% | ROA | 6,58% |
| Gross Margin | 39,00% | Operating Margin | 15,07% |
| Net Margin | 11,68% | Free Cash Flow (TTM) | -128,95M |
| ROIC | 8,94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,39 | Current Ratio | 0,86 |
| Interest Coverage | 16,99 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,31% |
| Dividend Growth (3Y) | 30,45% | Dividend Growth (5Y) | 45,42% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 57,37 | Forward P/E | 30,70 |
| P/B Ratio | 7,39 | P/S Ratio | 6,70 |
| PEG Ratio | 4,28 | Forward PEG | N/A |
| EV/EBITDA | 46,53 | Fwd EV/EBITDA | 30,59 |
| Forward P/S | 6,92 | Fwd Earnings Yield | 3,26% |
| FCF Yield | -2,57% | ||
| Market Cap | 5,02B | Enterprise Value | 5,25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 748,87M | 548,46M | 497,46M | 464,84M | 403,66M |
| Net Income | 87,50M | 78,37M | 51,28M | 23,11M | 5,81M |
| EPS (Diluted) | 6,41 | 5,74 | 3,82 | 1,82 | 0,46 |
| Gross Profit | 292,07M | 189,05M | 140,59M | 113,82M | 94,83M |
| Operating Income | 112,85M | 86,22M | 37,30M | 24,40M | 769 000,0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,33B | 1,10B | 861,88M | 756,91M | 717,68M |
| Total Liabilities | 650,66M | 483,66M | 291,57M | 356,63M | 313,54M |
| Shareholders' Equity | 679,69M | 617,73M | 562,33M | 392,54M | 395,39M |
| Total Debt | 267,00M | 256,00M | 157,00M | 267,00M | 215,00M |
| Cash & Equivalents | 36,50M | 74,02M | 24,48M | 15,86M | 18,15M |
| Current Assets | 426,95M | 337,95M | 208,33M | 193,58M | 185,14M |
| Current Liabilities | 496,19M | 440,22M | 258,99M | 237,34M | 272,38M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Heavy Grower
#62 of 77
Activité Récente
Entré
Capital Heavy Grower
Mar 24, 2026